Elevated plasma CXCL9 and CHI3L1 prior to HCT predict post‐HCT lung complications in children
In conclusion, we have identified two potential biomarkers of post-HCT lung disease in paediatric patients and these require validation in future cohorts.
Authors
- Melanie R. Neeland (ORCID: https://orcid.org/0000-0001-7301-9982)
- Hannah Walker (ORCID: https://orcid.org/0000-0002-3851-7502)
- Theresa Cole (ORCID: https://orcid.org/0000-0002-8272-4074)
- Liam Gubbels (ORCID: https://orcid.org/0000-0002-8132-9646)
- Gabrielle M. Haeusler (ORCID: https://orcid.org/0000-0003-0371-8176)
- Shivanthan Shanthikumar (ORCID: https://orcid.org/0000-0001-6000-3180)
- Diane T. Hanna (ORCID: https://orcid.org/0000-0003-1162-9341)
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Murdoch Children's Research Institute (AU)
- Paediatric Integrated Cancer Service (AU)
- National Health and Medical Research Council (AU)
Publication Details
- Journal
- Clinical & Translational Immunology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1002/cti2.70064
- Primary Topic
- Chemokine receptors and signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Children’s Hospital of Wisconsin Research Institute
- Children's Hospital Foundation
- Murdoch Children's Research Institute